Oramed pharmaceuticals inc. (ORMP)
Income statement / Yearly
Aug'19Aug'18Aug'17Aug'16Aug'15Aug'14Aug'13Aug'12Aug'11
REVENUES

2,703

2,449

2,456

641

0

0

-

-

-

COST OF REVENUES (INCOME) (note 6o)

-

-

-

490

-

-

-

-

-

COST OF REVENUES

90

-86

187

-

0

0

-

-

-

RESEARCH AND DEVELOPMENT EXPENSES

13,522

11,979

10,281

7,709

4,781

3,277

-2,272

1,681

1,159

IMPAIRMENT OF INVESTMENT

-

-

-

-

-

-

-

-

0

GENERAL AND ADMINISTRATIVE EXPENSES

3,722

4,083

2,759

2,452

2,602

2,629

-2,032

1,203

1,275

OPERATING LOSS

-14,631

-13,527

-10,771

-10,010

-7,383

-5,906

4,304

-2,884

-2,435

FINANCIAL INCOME

1,061

903

792

474

168

225

-180

13

33

GAIN ON SALE OF INVESTMENT

-

-

-

-

-

-

-

-

1,033

IMPAIRMENT OF AVAILABLE- FOR-SALE SECURITIES

-

-

-

-

-

-

-

184

197

FINANCIAL EXPENSES

485

103

101

93

18

11

-313

199

18

LOSS BEFORE TAXES ON INCOME

-14,055

-12,727

-10,080

-9,629

-7,233

-5,692

4,437

-3,254

-1,585

TAXES ON INCOME

300

-

400

1,335

-1

4

205

90

-23

NET LOSS FOR THE PERIOD

-14,355

-12,727

-10,480

-10,964

-7,232

-5,696

4,232

-3,344

-1,561

SUBSEQUENT INCREASE IN THE FAIR VALUE OF AVAILABLE FOR SALE SECURITIES PREVIOUSLY WRITTEN DOWN AS IMPAIRED

-

-

-

-

-

-

-131

0

-

RECLASSIFICATION ADJUSTMENT FOR GAINS INCLUDED IN NET LOSS

-

-

-

-

-

80

-90

0

-

UNREALIZED INCOME ON AVAILABLE FOR SALE SECURITIES

-

301

295

-452

106

228

-263

0

-

TOTAL OTHER COMPREHENSIVE INCOME

-

301

295

-452

106

148

-304

0

-

TOTAL COMPREHENSIVE LOSS FOR THE PERIOD

-14,355

-12,426

-10,185

-11,416

-7,126

-5,548

3,928

-3,344

-

LOSS PER SHARE OF COMMON STOCK:
BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK

0.82

0.86

0.79

0.87

0.67

0.62

0.59

0.57

-0.02

WEIGHTED AVERAGE NUMBER OF SHARES OF COMMON STOCK USED IN COMPUTING BASIC AND DILUTED LOSS PER SHARE OF COMMON STOCK

17,454

14,882

13,309

12,624

10,820

9,244

7,209

5,884

-

WEIGHTED AVERAGE NUMBER OF BASIC AND DILUTED SHARES USED IN COMPUTATION OF LOSS PER SHARE:

-

-

-

-

-

-

-

-

64,999